3Q 2015 IMS
News Release
Aviva plc
Interim management statement to 30 September 2015
29 October 2015
Aviva plc Third Quarter 2015
Interim Management Statement
Mark Wilson, Group Chief Executive Officer, said:
"We are maintaining the momentum of Aviva's transformation with a further quarter of improved performance. In life insurance, value of new business was up 25%¹, the eleventh consecutive quarter of growth. The general insurance combined ratio of 94.0% is a more than adequate result. This level of consistency is important as we transform and grow Aviva.
"The acquisition of Friends Life is everything we expected it to be. We have now achieved £91 million of savings against our target of £225 million. At the same time our UK Life business continues to grow and our customers are responding positively to the full range of pensions freedoms we offer.
"In asset management, our flagship fund range, AIMS, continues its strong investment performance and the Target Return Fund has recorded returns of 6.6% over the past 12 months. AIMS now has £1.9 billion of funds under management. We expect this growth to continue."
9M15 numbers include Friends Life from 10 April 2015, the acquisition completion date. 9M14 is Aviva standalone.
|
Life Insurance |
· Value of new business² (VNB) grew 25%¹ to £823 million (9M14: £685 million) · UK Life VNB grew 36% to £404 million (9M14: £297 million), up 13% excluding Friends Life · Aviva platforms continue to grow with over £2.2 billion of net inflows in the nine months to 30th September 2015 taking AUM to £7.3 billion · Europe2 VNB grew 11%1 to £284 million with particularly strong growth in Italy2 up 55%1 to £57 million. Asia2 VNB up 21%1 to £115 million (9M14: £92 million) |
General Insurance |
· Combined operating ratio (COR) improved to 94.0% (9M14: 95.9%) · UK & Ireland COR of 92.8% (9M14: 94.2%), Canada COR of 94.2% (9M14: 96.8%), Europe COR of 97.1% (9M14: 99.8%) · GI and health net written premiums up 2%1 to £6,110 million |
1Asset Management |
· AIMS Target Return fund continues to outperform peers with a return of 6.6% over the past 12 months. The AIMS suite of funds now has £1.9 billion under management. |
1Balance sheet |
· IFRS net asset value up 2% to 387p per share (HY15: 380p) · Resilient capital position throughout recent market volatility with an economic capital surplus3 of £10.1 billion (HY15: £10.8 billion), a coverage ratio of 172% (HY15: 176%) performing in line with our published sensitivities · S&P revised upwards the financial risk profile of the Group to strong and S&P leverage ratio remains stable at 27% (HY15: 27%4) |
1Friends Life integration |
· £91 million of run-rate synergies achieved against a £225 million target - ahead of plan · £23 billion of Friends Life assets due to be transferred from AXA Investment Managers in November |
1 On a constant currency basis.
2 Poland includes Lithuania, Italy excludes Eurovita, Spain excludes CxG and Asia excludes South Korea.
3 The economic capital surplus represents an estimated position. The economic capital requirement is based on Aviva's own internal assessment and capital management policies. The term 'economic capital' does not imply capital as required by regulators or other third parties.
4 HY15 S&P leverage ratio is on a pro-forma basis, taking account of planned redemptions, calls and other reductions of debt in Q3 2015.
Page 2
Key financial metrics
Operating capital generation
|
|
9 months 2015 £bn |
9 months 2014 £bn |
|
United Kingdom & Ireland Life |
0.7 |
0.5 |
|
United Kingdom & Ireland General Insurance & Health |
0.3 |
0.3 |
|
Europe |
0.3 |
0.4 |
|
Canada |
0.1 |
0.1 |
|
Asia and Other |
- |
- |
|
Total |
1.4 |
1.3 |
Value of new business
|
|
9 months 2015 |
9 months 2014 |
Sterling % change1 |
Constant currency % change1 |
|
United Kingdom & Ireland |
415 |
303 |
37% |
38% |
|
France |
144 |
156 |
(8)% |
2% |
|
Poland2 |
46 |
46 |
- |
11% |
|
Italy2 |
57 |
41 |
39% |
55% |
|
Spain2 |
20 |
19 |
3% |
15% |
|
Turkey |
17 |
23 |
(25)% |
(15)% |
|
Asia2 |
115 |
92 |
24% |
21% |
|
Aviva Investors |
9 |
5 |
72% |
72% |
|
Value of new business2 |
823 |
685 |
20% |
25% |
General insurance combined operating ratio
|
|
9 months 2015 |
9 months 2014 |
Change |
|
United Kingdom & Ireland3 |
92.8% |
94.2% |
(1.4)pp |
|
Europe |
97.1% |
99.8% |
(2.7)pp |
|
Canada |
94.2% |
96.8% |
(2.6)pp |
|
General insurance combined operating ratio |
94.0% |
95.9% |
(1.9)pp |
Capital position
|
|
30 September 2015 £bn |
30 June 2015 £bn |
Sterling% change |
|
Estimated economic capital surplus4 |
10.1 |
10.8 |
(6)% |
|
Estimated IGD solvency surplus4 |
5.2 |
5.2 |
- |
|
IFRS net asset value per share |
387p |
380p |
2% |
|
MCEV net asset value per share5 |
504p |
508p |
(1)% |
1 Currency movements are calculated using unrounded numbers so minor rounding differences may exist.
2 Poland includes Lithuania, Italy excludes Eurovita, Spain excludes CxG and Asia excludes South Korea.
3 Excludes the one-off impact from an outward quota share reinsurance agreement completed in 2015 in Aviva Insurance Limited (AIL).
4 The economic capital and IGD surpluses represent an estimated position. The economic capital requirement is based on Aviva's own internal assessment and capital management policies. The term 'economic capital' does not imply capital as required by regulators or other third parties.
5 In preparing the MCEV information, the directors have done so in accordance with the European Insurance CFO Forum MCEV Principles.
Page 3
Chief Executive Officer's report
|
Overview |
We are maintaining the momentum of Aviva's transformation. Value of new business is up 25%¹ to £823 million (9M14: £685 million2), the combined operating ratio has improved to 94.0% (9M14: 95.9%) and run-rate synergies from the Friends Life acquisition have grown to £91 million (HY15: £63 million).
Our economic capital has remained resilient at 172% despite significant market volatility in the third quarter, with our capital sensitivities proving accurate. We expect a positive outcome to our Solvency II internal model application, due to be announced in December this year. We have completed two projects to further improve our balance sheet, reinsuring the majority of our UK general insurance latent risk portfolio in September and disposing of a £2.2 billion portfolio of non-core commercial mortgages in October.
Work continues to transform Aviva into a leading digital insurer and we will open our second Digital Garage in Singapore in December. We are seeing encouraging growth in the volume of customer interactions that are completed online, albeit from a low base. We continue to develop our suite of digital propositions to be implemented across our business units. |
|
Life Insurance
· Value of new business up 25% in constant currency · UK Life up 36%
|
Value of new business, our growth measure for life insurance, increased 25% in constant currency to £823 million (9M14: £685 million2).
VNB in the UK grew 36% to £404 million. Excluding Friends Life, UK VNB was 13% higher at £335 million, principally reflecting improved performance in pensions. All UK Life customers are now able to benefit from the full range of pensions freedoms on our consumer platform. Total assets on our platforms now stand at £7.3 billion with 25% of platform net flows being invested with Aviva Investors. Ireland Life VNB grew 110%1 to £11 million as a result of higher margins in pensions and savings products.
In our developed European markets, France VNB grew 2%1 to £144 million principally due to higher sales and improved margin on protection products, partly offset by lower margins on savings products as a result of lower risk free rates. Italy2 continued its strong turnaround, with 55%1 growth in VNB to £57 million (9M14: £41 million), reflecting improved margins on savings and protection products, while in Spain2 VNB grew by a creditable 15%1.
Performance in our growth markets remained positive with attractive underlying trends. These businesses account for 22% of our Group VNB and we will look to allocate more capital to these areas. Poland2 VNB was 11%1 higher at £46 million despite the non recurrence of an £8 million benefit to VNB in 2014 from pension regulatory change. In Turkey, VNB fell 15%1 to £17 million (9M14: £23 million) as the impact of underlying growth was offset by a reduction in our share of the business following the partial IPO. Asia2 grew 21%1 as strong performances in China and Singapore were partly offset by India. |
|
Friends Life |
At the end of the third quarter we have secured run-rate synergies of £91 million, an increase of £28 million from the half year against a £225 million target. The transfer of £23 billion of Friends Life assets from AXA Investment Managers is due to occur in November. Overall capital synergies from the acquisition are expected to be material. The integration is progressing well and ahead of our internal timetable.
The acquisition of Friends Life has created the largest life insurer in the UK. As a result we are in a strong position to look after our customers' entire savings, pensions and retirement needs. For example, we offer the full range of pension freedoms; we are the number one corporate pension provider and have recently launched our new combined Group protection proposition. |
1 On a constant currency basis.
2 Poland includes Lithuania, Italy excludes Eurovita, Spain excludes CxG and Asia excludes South Korea.
Page 4
Group Chief Executive Officer's report continued
|
General Insurance
· COR improved 1.9pp to 94.0% · GI and health net
|
Our general insurance combined operating ratio (COR) improved 1.9 percentage points to 94.0% (9M14: 95.9%) due to lower weather losses and improved efficiency. General insurance and health net written premiums were 2% higher in constant currency at £6,110 million.
The UK & Ireland COR improved 1.4 percentage points to 92.8% (9M14: 94.2%), with growth in net written premiums continuing with a 1%¹ improvement. We continue to reshape our distribution and portfolio mix, exiting unprofitable lines of business and reallocating capital to our Digital & True Customer Composite propositions. Further to our announcement at the half year of our new distribution agreement with TSB, we are announcing today a new exclusive five year agreement to underwrite home assistance products for HomeServe's 2 million UK customers.
In Canada, the COR improved 2.6 percentage points to 94.2% (9M14: 96.8%) reflecting better overall weather experience, offset mainly by large loss experience in personal property. Net written premiums are 2%1 higher despite selected exits from unprofitable business lines.
The European COR improved to 97.1% (9M14: 97.7%2) through a combination of better weather in France and a lower expense ratio across all markets. General insurance and health net written premiums grew 3%2 to £1,067 million on a constant currency basis. |
|
Asset Management
· AIMS now has £1.9 billion of FUM
|
Aviva Investors continues to make progress on its turnaround during a period of difficult industry conditions. Gross sales of £4.0 billion are encouraging and are at a higher margin than redemptions, which remain too high at £4.5 billion.
The AIMS flagship range of funds continues its strong performance versus peers and now has £1.9 billion of funds under management. During the third quarter, performance has been broadly flat versus the FTSE 100 which has dropped 6%, and over the past 12 months the Target Return Fund has outperformed peers and recorded returns of 6.6%. Our partnership with Virtus Investment Partners in the United States launched successfully and we continue to seek more international distribution agreements. |
|
Balance sheet
· Economic capital
|
Aviva's balance sheet remains strong with a 3Q15 economic capital surplus3 of £10.1 billion (HY15: £10.8 billion). Our coverage ratio of 172% has been resilient during the volatile investment markets seen in the third quarter and has performed as expected and in line with published sensitivities.
Our IFRS book value per share increased 2% over the quarter to 387p per share (HY15: 380p). Operating profits and a small increase in our pension surplus more than offset the negative impact of investment variances.
During the quarter, we completed a reinsurance transaction that includes provision of c.£0.8 billion of adverse development cover for our UK General Insurance latent reserves. This provides significant protection against claims volatility from mesothelioma, industrial deafness and other long tail risks. The transaction produces an economic capital benefit of c.£0.1 billion and will lead to a one-off IFRS loss before tax of c.£56 million. There will be an on-going reduction in investment income, estimated at c.£10 million per annum, as a result of transferring assets to settle the reinsurance premium.
In UK Life, we disposed of £2.2 billion of non-core commercial mortgages in October. |
|
Solvency II
|
We expect to obtain approval for our internal model in December 2015 and whilst we are in the process of finalising the remaining issues, we are comfortable with our level of capital and satisfied that it will be within our expected Solvency II range.
We will report our Solvency II numbers for the first time at our full year results in March 2016 and we will also provide our target capital range, sensitivities and roadmap for capital going forward at that time. |
1 On a constant currency basis.
2 Excluding the Turkish general insurance business disposed of in December 2014.
3 The economic capital surplus represents an estimated position. The economic capital requirement is based on Aviva's own internal assessment and capital management policies. The term 'economic capital' does not imply capital as required by regulators or other third parties.
Page 5
Group Chief Executive Officer's report continued
|
Digital
|
Digital remains crucial to our future success and our position as a True Customer Composite gives us a strategic advantage. Our second digital garage will be opened in Singapore in December. Good progress has been made in hiring our global digital leadership team, bringing industry leading expertise in digital design and digital marketing. We are seeing encouraging growth in the volume of customer interactions that are completed online, and continue to develop our suite of digital propositions to be implemented across our business units. |
|
Outlook
|
Our near term priorities are clear; we are focused on delivering the benefits from the Friends Life integration and the transition to Solvency II. Beyond that, there exists significant upside from better capital allocation and a more effective digital customer proposition.
The third quarter results are further evidence of our progress since we started our turnaround. We remain focused on showing improvement in our key metrics year after year. |
Mark Wilson
Group Chief Executive Officer
Page 6
Notes to editors
All comparators are for the 9 months to 30 September 2014 unless otherwise stated.
Income and expenses of foreign entities are translated at average exchange rates while their assets and liabilities are translated at the closing rates on 30 September 2015. The average rates employed in this announcement are 1 euro = £0.73 (9 months to 30 September 2014: 1 euro = £0.81) and CAD$1 = £0.52 (9 months to 30 September 2014: CAD$1 = £0.55).
Growth rates in the press release have been provided in sterling terms unless stated otherwise. The following supplement presents this information on both a sterling and constant currency basis.
Cautionary statements:
This should be read in conjunction with the documents filed by Aviva plc (the "Company" or "Aviva") with the United States Securities and Exchange Commission ("SEC"). This announcement contains, and we may make other verbal or written "forward-looking statements" with respect to certain of Aviva's plans and current goals and expectations relating to future financial condition, performance, results, strategic initiatives and objectives. Statements containing the words "believes", "intends", "expects", "projects", "plans", "will," "seeks", "aims", "may", "could", "outlook", "likely", "target", "goal", "guidance", "trends", "future", "estimates", "potential" and "anticipates", and words of similar meaning, are forward-looking. By their nature, all forward-looking statements involve risk and uncertainty. Accordingly, there are or will be important factors that could cause actual results to differ materially from those indicated in these statements. Aviva believes factors that could cause actual results to differ materially from those indicated in forward-looking statements in the announcement include, but are not limited to: the impact of ongoing difficult conditions in the global financial markets and the economy generally; the impact of simplifying our operating structure and activities; the impact of various local political, regulatory and economic conditions; market developments and government actions regarding the sovereign debt crisis in Europe; the effect of credit spread volatility on the net unrealised value of the investment portfolio; the effect of losses due to defaults by counterparties, including potential sovereign debt defaults or restructurings, on the value of our investments; changes in interest rates that may cause policyholders to surrender their contracts, reduce the value of our portfolio and impact our asset and liability matching; the impact of changes in short or long term inflation; the impact of changes in equity or property prices on our investment portfolio; fluctuations in currency exchange rates; the effect of market fluctuations on the value of options and guarantees embedded in some of our life insurance products and the value of the assets backing their reserves; the amount of allowances and impairments taken on our investments; the effect of adverse capital and credit market conditions on our ability to meet liquidity needs and our access to capital; changes in, or restrictions on, our ability to initiate capital management initiatives or an acceleration of repayment of intercompany indebtedness; changes in or inaccuracy of assumptions in pricing and reserving for insurance business (particularly with regard to mortality and morbidity trends, lapse rates and policy renewal rates), longevity and endowments; a cyclical downturn of the insurance industry; the impact of natural and man-made catastrophic events on our business activities and results of operations; our reliance on information and technology and third-party service providers for our operations and systems; the inability of reinsurers to meet obligations or unavailability of reinsurance coverage; increased competition in the UK and in other countries where we have significant operations; the effect of the European Union's "Solvency II" rules on our regulatory capital requirements; the impact of actual experience differing from estimates used in valuing and amortising deferred acquisition costs ("DAC") and acquired value of in-force business ("AVIF"); the impact of recognising an impairment of our goodwill or intangibles with indefinite lives; changes in valuation methodologies, estimates and assumptions used in the valuation of investment securities; the effect of legal proceedings and regulatory investigations; the impact of operational risks, including inadequate or failed internal and external processes, systems and human error or from external events; risks associated with arrangements with third parties, including joint ventures; our reliance on third-party distribution channels to deliver our products; funding risks associated with our participation in defined benefit staff pension schemes; the failure to attract or retain the necessary key personnel; the effect of systems errors or regulatory changes on the calculation of unit prices or deduction of charges for our unit-linked products that may require retrospective compensation to our customers; the effect of fluctuations in share price as a result of general market conditions or otherwise; the effect of simplifying our operating structure and activities; the effect of a decline in any of our ratings by rating agencies on our standing among customers, broker-dealers, agents, wholesalers and other distributors of our products and services; changes to our brand and reputation; changes in government regulations or tax laws in jurisdictions where we conduct business, including decreased demand for annuities in the UK due to changes in UK law; the inability to protect our intellectual property; the effect of undisclosed liabilities, integration issues and other risks associated with our acquisitions; and the timing/regulatory approval impact, integration risk and other uncertainties, such as non-realisation of expected benefits or diversion of management attention and other resources, relating to announced acquisitions and pending disposals and relating to future acquisitions, combinations or disposals within relevant industries, including specifically the acquisition of Friends Life; the policies, decisions and actions of government or regulatory authorities in the UK, the EU, the US or elsewhere, including the implementation of key legislation and regulation. For a more detailed description of these risks, uncertainties and other factors, please see Item 3d, "Risk Factors", and Item 5, "Operating and Financial Review and Prospects" in Aviva's most recent Annual Report on Form 20-F as filed with the SEC on 16 March 2015 and also the risk factors contained in the Euro Note Programme prospectus published on 1 May 2015. Aviva undertakes no obligation to update the forward looking statements in this announcement or any other forward-looking statements we may make. Forward-looking statements in this presentation are current only as of the date on which such statements are made.
Aviva plc is a company registered in England No. 2468686.
Registered office
St Helen's
1 Undershaft
London
EC3P 3DQ
Contacts
|
Investor contacts |
Media contacts |
Timings |
|
Colin Simpson David Elliot |
Nigel Prideaux Andrew Reid Sarah Swailes |
Real time media conference call: 07.30 hrs GMT Analyst conference call: 08.30 hrs GMT Tel: +44 (0)20 3367 9433 Conference ID: 511455 |
Page 7
Statistical supplement
1. Basis of preparation
2. Trend analysis of VNB - cumulative
3. Trend analysis of VNB - discrete
4. Trend analysis of PVNBP - cumulative
5. Trend analysis of PVNBP - discrete
6. Trend analysis of PVNBP by product - cumulative
7. Trend analysis of PVNBP by product - discrete
8. Geographical analysis of regular and single premiums
9. Trend analysis of Investment sales - cumulative
10. Trend analysis of Investment sales - discrete
11. Geographical analysis of regular and single premiums - investment sales
12. Trend analysis of general insurance and health net written premiums - cumulative
13. Trend analysis of general insurance and health net written premiums - discrete
Page 8
1 - Basis of preparation
The information included in this announcement and statistical supplement includes the results of Friends Life from 10 April 2015, the acquisition completion date. For the avoidance of doubt, all results for periods prior to 2Q15 are Aviva standalone.
2 - Trend analysis of VNB - cumulative
|
|
|
|
|
|
|
|
|
|
Growth1 on 3Q14 |
|
Gross of tax and non-controlling interests |
1Q14 YTD |
2Q14 YTD |
3Q14 YTD £m |
4Q14 YTD £m |
1Q15 YTD £m |
2Q15 YTD £m |
3Q15 YTD £m |
Sterling |
Constant currency % |
|
United Kingdom2 |
89 |
177 |
297 |
473 |
103 |
253 |
404 |
36% |
36% |
|
Ireland |
3 |
6 |
6 |
9 |
3 |
7 |
11 |
89% |
110% |
|
United Kingdom & Ireland |
92 |
183 |
303 |
482 |
106 |
260 |
415 |
37% |
38% |
|
France |
54 |
110 |
156 |
205 |
56 |
98 |
144 |
(8)% |
2% |
|
Poland3 |
21 |
34 |
46 |
64 |
15 |
30 |
46 |
- |
11% |
|
Italy - excluding Eurovita |
15 |
26 |
41 |
63 |
19 |
39 |
57 |
39% |
55% |
|
Spain - excluding CxG |
6 |
14 |
19 |
30 |
6 |
13 |
20 |
3% |
15% |
|
Turkey4 |
6 |
14 |
23 |
30 |
6 |
12 |
17 |
(25)% |
(15)% |
|
Europe |
102 |
198 |
285 |
392 |
102 |
192 |
284 |
(1)% |
11% |
|
Asia5 - excluding South Korea |
29 |
61 |
92 |
122 |
36 |
76 |
115 |
24% |
21% |
|
Aviva Investors6 |
- |
2 |
5 |
9 |
3 |
6 |
9 |
72% |
72% |
|
Value of new business - excluding Eurovita, CxG & South Korea |
223 |
444 |
685 |
1,005 |
247 |
534 |
823 |
20% |
25% |
|
Eurovita, CxG & South Korea |
1 |
- |
1 |
4 |
- |
- |
- |
- |
- |
|
Total value of new business |
224 |
444 |
686 |
1,009 |
247 |
534 |
823 |
20% |
25% |
1 Currency movements are calculated using unrounded numbers so minor rounding differences may exist.
2 United Kingdom includes Friends UK from 10 April 2015.
3 Poland includes Lithuania.
4 The shareholding of Aviva's minority interest in our Turkish joint venture reduced from 49.8% to 41.3% on 13 November 2014 through an initial public offering. Aviva's holding was further reduced to 40.0% on 7 August 2015.
5 Asia includes FPI from 10 April 2015.
6 The UK Retail Fund Management business was transferred from UK Life to Aviva Investors on 9 May 2014.
3 - Trend analysis of VNB - discrete
|
|
|
|
|
|
|
|
|
|
Growth1 on 3Q14 |
|
Gross of tax and non-controlling interests |
1Q14 Discrete |
2Q14 Discrete |
3Q14 Discrete |
4Q14 Discrete |
1Q15 Discrete |
2Q15 Discrete |
3Q15 Discrete |
Sterling |
Constant currency |
|
United Kingdom2 |
89 |
88 |
120 |
176 |
103 |
150 |
151 |
26% |
26% |
|
Ireland |
3 |
3 |
- |
3 |
3 |
4 |
4 |
- |
- |
|
United Kingdom & Ireland |
92 |
91 |
120 |
179 |
106 |
154 |
155 |
31% |
30% |
|
France |
54 |
56 |
46 |
49 |
56 |
42 |
46 |
- |
9% |
|
Poland3 |
21 |
13 |
12 |
18 |
15 |
15 |
16 |
33% |
43% |
|
Italy - excluding Eurovita |
15 |
11 |
15 |
22 |
19 |
20 |
18 |
22% |
34% |
|
Spain - excluding CxG |
6 |
8 |
5 |
11 |
6 |
7 |
7 |
47% |
60% |
|
Turkey4 |
6 |
8 |
9 |
7 |
6 |
6 |
5 |
(42)% |
(35)% |
|
Europe |
102 |
96 |
87 |
107 |
102 |
90 |
92 |
7% |
17% |
|
Asia5 - excluding South Korea |
29 |
32 |
31 |
30 |
36 |
40 |
39 |
25% |
23% |
|
Aviva Investors6 |
- |
2 |
3 |
4 |
3 |
3 |
3 |
(17)% |
(17)% |
|
Value of new business - excluding Eurovita, CxG & South Korea |
223 |
221 |
241 |
320 |
247 |
287 |
289 |
20% |
24% |
|
Eurovita, CxG & South Korea |
1 |
(1) |
1 |
3 |
- |
- |
- |
- |
- |
|
Total value of new business |
224 |
220 |
242 |
323 |
247 |
287 |
289 |
19% |
23% |
1 Currency movements are calculated using unrounded numbers so minor rounding differences may exist.
2 United Kingdom includes Friends UK from 10 April 2015.
3 Poland includes Lithuania.
4 The shareholding of Aviva's minority interest in our Turkish joint venture reduced from 49.8% to 41.3% on 13 November 2014 through an initial public offering. Aviva's holding was further reduced to 40.0% on 7 August 2015.
5 Asia includes FPI from 10 April 2015.
6 The UK Retail Fund Management business was transferred from UK Life to Aviva Investors on 9 May 2014.
Page 9
4 - Trend analysis of PVNBP - cumulative
|
|
|
|
|
|
|
|
|
|
Growth2 on 3Q14 |
|
Present value of new business premiums1 |
1Q14 YTD £m |
2Q14 YTD £m |
3Q14 YTD £m |
4Q14 YTD £m |
1Q15 YTD £m |
2Q15 YTD £m |
3Q15 YTD £m |
Sterling |
Constant currency % |
|
United Kingdom3,8 |
2,931 |
6,052 |
9,098 |
12,009 |
2,445 |
7,071 |
11,696 |
29% |
29% |
|
Ireland |
105 |
196 |
291 |
435 |
132 |
270 |
406 |
39% |
55% |
|
United Kingdom & Ireland |
3,036 |
6,248 |
9,389 |
12,444 |
2,577 |
7,341 |
12,102 |
29% |
29% |
|
France |
1,310 |
2,427 |
3,538 |
4,633 |
1,319 |
2,553 |
3,639 |
3% |
15% |
|
Poland4 |
234 |
332 |
429 |
573 |
110 |
218 |
319 |
(26)% |
(18)% |
|
Italy - excluding Eurovita |
698 |
1,440 |
2,060 |
2,473 |
603 |
1,116 |
1,518 |
(26)% |
(18)% |
|
Spain - excluding CxG |
270 |
536 |
743 |
1,054 |
224 |
363 |
455 |
(39)% |
(32)% |
|
Turkey5 |
110 |
231 |
348 |
495 |
134 |
251 |
347 |
- |
12% |
|
Europe |
2,622 |
4,966 |
7,118 |
9,228 |
2,390 |
4,501 |
6,278 |
(12)% |
(2)% |
|
Asia6 - excluding South Korea |
421 |
867 |
1,357 |
1,854 |
623 |
1,449 |
2,218 |
63% |
60% |
|
Aviva Investors7 |
5 |
257 |
562 |
881 |
366 |
761 |
1,165 |
107% |
107% |
|
Total - excluding Eurovita, CxG & South Korea |
6,084 |
12,338 |
18,426 |
24,407 |
5,956 |
14,052 |
21,763 |
18% |
23% |
|
Eurovita, CxG & South Korea |
136 |
292 |
307 |
321 |
- |
- |
- |
- |
- |
|
Total |
6,220 |
12,630 |
18,733 |
24,728 |
5,956 |
14,052 |
21,763 |
16% |
21% |
1 Present value of new business premiums (PVNBP) is the present value of new regular premiums plus 100% of single premiums, calculated using assumptions consistent with those used to determine the value of new business.
2 Currency movements are calculated using unrounded numbers so minor rounding differences may exist.
3 United Kingdom includes Friends UK from 10 April 2015.
4 Poland includes Lithuania.
5 The shareholding of Aviva's minority interest in our Turkish joint venture reduced from 49.8% to 41.3% on 13 November 2014 through an initial public offering. Aviva's holding was further reduced to 40.0% on 7 August 2015.
6 Asia includes FPI from 10 April 2015.
7 The UK Retail Fund Management business was transferred from UK Life to Aviva Investors on 9 May 2014.
8 Includes c.£1 billion PVNBP (net of reinsurance) relating to a longevity insurance transaction completed in 3Q15.
5 - Trend analysis of PVNBP - discrete
|
|
|
|
|
|
|
|
|
|
Growth2 on 3Q14 |
|
Present value of new business premiums1 |
1Q14 Discrete £m |
2Q14 Discrete £m |
3Q14 Discrete £m |
4Q14 Discrete £m |
1Q15 Discrete £m |
2Q15 Discrete £m |
3Q15 Discrete £m |
Sterling |
Constant currency % |
|
United Kingdom3,8 |
2,931 |
3,121 |
3,046 |
2,911 |
2,445 |
4,626 |
4,625 |
52% |
52% |
|
Ireland |
105 |
91 |
95 |
144 |
132 |
138 |
136 |
42% |
56% |
|
United Kingdom & Ireland |
3,036 |
3,212 |
3,141 |
3,055 |
2,577 |
4,764 |
4,761 |
52% |
52% |
|
France |
1,310 |
1,117 |
1,111 |
1,095 |
1,319 |
1,234 |
1,086 |
(2)% |
7% |
|
Poland4 |
234 |
98 |
97 |
144 |
110 |
108 |
101 |
4% |
11% |
|
Italy - excluding Eurovita |
698 |
742 |
620 |
413 |
603 |
513 |
402 |
(35)% |
(29)% |
|
Spain - excluding CxG |
270 |
266 |
207 |
311 |
224 |
139 |
92 |
(56)% |
(52)% |
|
Turkey5 |
110 |
121 |
117 |
147 |
134 |
117 |
96 |
(18)% |
(7)% |
|
Europe |
2,622 |
2,344 |
2,152 |
2,110 |
2,390 |
2,111 |
1,777 |
(17)% |
(10)% |
|
Asia6 - excluding South Korea |
421 |
446 |
490 |
497 |
623 |
826 |
769 |
57% |
55% |
|
Aviva Investors7 |
5 |
252 |
305 |
319 |
366 |
395 |
404 |
33% |
33% |
|
Total - excluding Eurovita, CxG & South Korea |
6,084 |
6,254 |
6,088 |
5,981 |
5,956 |
8,096 |
7,711 |
27% |
31% |
|
Eurovita, CxG & South Korea |
136 |
156 |
15 |
14 |
- |
- |
- |
- |
- |
|
Total |
6,220 |
6,410 |
6,103 |
5,995 |
5,956 |
8,096 |
7,711 |
26% |
30% |
1 Present value of new business premiums (PVNBP) is the present value of new regular premiums plus 100% of single premiums, calculated using assumptions consistent with those used to determine the value of new business.
2 Currency movements are calculated using unrounded numbers so minor rounding differences may exist.
3 United Kingdom includes Friends UK from 10 April 2015.
4 Poland includes Lithuania.
5 The shareholding of Aviva's minority interest in our Turkish joint venture reduced from 49.8% to 41.3% on 13 November 2014 through an initial public offering. Aviva's holding was further reduced to 40.0% on 7 August 2015.
6 Asia includes FPI from 10 April 2015.
7 The UK Retail Fund Management business was transferred from UK Life to Aviva Investors on 9 May 2014.
8 Includes c.£1 billion PVNBP (net of reinsurance) relating to a longevity insurance transaction completed in 3Q15.
Page 10
6 - Trend analysis of PVNBP by product - cumulative
|
|
|
|
|
|
|
|
|
|
Growth2 on 3Q14 |
|
Present value of new business premiums1 |
1Q14 YTD £m |
2Q14 YTD £m |
3Q14 YTD £m |
4Q14 YTD £m |
1Q15 YTD £m |
2Q15 YTD £m |
3Q15 YTD £m |
Sterling |
Constant currency % |
|
Pensions |
1,328 |
2,794 |
4,081 |
5,803 |
1,319 |
3,897 |
6,085 |
49% |
49% |
|
Annuities8 |
500 |
935 |
1,656 |
1,948 |
136 |
777 |
2,205 |
33% |
33% |
|
Bonds |
45 |
87 |
135 |
174 |
39 |
80 |
109 |
(19)% |
(19)% |
|
Protection |
297 |
568 |
862 |
1,103 |
268 |
712 |
1,152 |
34% |
34% |
|
Equity release |
117 |
257 |
462 |
696 |
206 |
458 |
584 |
26% |
26% |
|
Other3 |
644 |
1,411 |
1,902 |
2,285 |
477 |
1,147 |
1,561 |
(18)% |
(18)% |
|
United Kingdom4 |
2,931 |
6,052 |
9,098 |
12,009 |
2,445 |
7,071 |
11,696 |
29% |
29% |
|
Ireland |
105 |
196 |
291 |
435 |
132 |
270 |
406 |
39% |
55% |
|
United Kingdom & Ireland |
3,036 |
6,248 |
9,389 |
12,444 |
2,577 |
7,341 |
12,102 |
29% |
29% |
|
Savings |
1,232 |
2,278 |
3,347 |
4,368 |
1,224 |
2,389 |
3,423 |
2% |
14% |
|
Protection |
78 |
149 |
191 |
265 |
95 |
164 |
216 |
13% |
26% |
|
France |
1,310 |
2,427 |
3,538 |
4,633 |
1,319 |
2,553 |
3,639 |
3% |
15% |
|
Pensions |
302 |
465 |
631 |
904 |
192 |
356 |
493 |
(22)% |
(13)% |
|
Savings |
890 |
1,819 |
2,583 |
3,182 |
754 |
1,330 |
1,767 |
(32)% |
(24)% |
|
Annuities |
2 |
2 |
3 |
5 |
- |
1 |
1 |
(56)% |
(50)% |
|
Protection |
118 |
253 |
363 |
504 |
125 |
261 |
378 |
4% |
16% |
|
Poland5, Italy5, Spain5 and Turkey6 |
1,312 |
2,539 |
3,580 |
4,595 |
1,071 |
1,948 |
2,639 |
(26)% |
(18)% |
|
Europe |
2,622 |
4,966 |
7,118 |
9,228 |
2,390 |
4,501 |
6,278 |
(12)% |
(2)% |
|
Asia5 |
421 |
867 |
1,357 |
1,854 |
623 |
1,449 |
2,218 |
63% |
60% |
|
Aviva Investors7 |
5 |
257 |
562 |
881 |
366 |
761 |
1,165 |
107% |
107% |
|
Total - excluding Eurovita, CxG & South Korea |
6,084 |
12,338 |
18,426 |
24,407 |
5,956 |
14,052 |
21,763 |
18% |
23% |
|
Eurovita, CxG & South Korea |
136 |
292 |
307 |
321 |
- |
- |
- |
- |
- |
|
Total |
6,220 |
12,630 |
18,733 |
24,728 |
5,956 |
14,052 |
21,763 |
16% |
21% |
1 Present value of new business premiums (PVNBP) is the present value of new regular premiums plus 100% of single premiums, calculated using assumptions consistent with those used to determine the value of new business.
2 Currency movements are calculated using unrounded numbers so minor rounding differences may exist.
3 Other UK business includes UK Retail Fund Management and UK long term health business. UK Retail Fund Management business was transferred from UK Life to Aviva Investors on 9 May 2014.
4 United Kingdom includes Friends UK from 10 April 2015.
5 Poland includes Lithuania, Italy excludes Eurovita, Spain excludes CxG. Asia includes FPI from 10 April 2015 and excludes South Korea.
6 The shareholding of Aviva's minority interest in our Turkish joint venture reduced from 49.8% to 41.3% on 13 November 2014 through an initial public offering. Aviva's holding was further reduced to 40.0% on 7 August 2015.
7 The UK Retail Fund Management business was transferred from UK Life to Aviva Investors on 9 May 2014.
8 Includes c.£1 billion PVNBP (net of reinsurance) relating to a longevity insurance transaction completed in 3Q15.
7 - Trend analysis of PVNBP by product - discrete
|
|
|
|
|
|
|
|
|
Growth2 |
|
|
Present value of new business premiums1 |
1Q14 Discrete £m |
2Q14 Discrete £m |
3Q14 Discrete £m |
4Q14 Discrete £m |
1Q15 Discrete £m |
2Q15 Discrete £m |
3Q15 Discrete £m |
Sterling |
Constant currency % |
|
Pensions |
1,328 |
1,466 |
1,287 |
1,722 |
1,319 |
2,578 |
2,188 |
70% |
70% |
|
Annuities8 |
500 |
435 |
721 |
292 |
136 |
641 |
1,428 |
98% |
98% |
|
Bonds |
45 |
42 |
48 |
39 |
39 |
41 |
29 |
(41)% |
(41)% |
|
Protection |
297 |
271 |
294 |
241 |
268 |
444 |
440 |
49% |
49% |
|
Equity release |
117 |
140 |
205 |
234 |
206 |
252 |
126 |
(39)% |
(39)% |
|
Other3 |
644 |
767 |
491 |
383 |
477 |
670 |
414 |
(15)% |
(15)% |
|
United Kingdom4 |
2,931 |
3,121 |
3,046 |
2,911 |
2,445 |
4,626 |
4,625 |
52% |
52% |
|
Ireland |
105 |
91 |
95 |
144 |
132 |
138 |
136 |
42% |
56% |
|
United Kingdom & Ireland |
3,036 |
3,212 |
3,141 |
3,055 |
2,577 |
4,764 |
4,761 |
52% |
52% |
|
Savings |
1,232 |
1,046 |
1,069 |
1,021 |
1,224 |
1,165 |
1,034 |
(3)% |
6% |
|
Protection |
78 |
71 |
42 |
74 |
95 |
69 |
52 |
25% |
36% |
|
France |
1,310 |
1,117 |
1,111 |
1,095 |
1,319 |
1,234 |
1,086 |
(2)% |
7% |
|
Pensions |
302 |
163 |
166 |
273 |
192 |
164 |
137 |
(17)% |
(9)% |
|
Savings |
890 |
929 |
764 |
599 |
754 |
576 |
437 |
(43)% |
(38)% |
|
Annuities |
2 |
- |
1 |
2 |
- |
1 |
- |
6% |
16% |
|
Protection |
118 |
135 |
110 |
141 |
125 |
136 |
117 |
5% |
15% |
|
Poland5, Italy5, Spain5 and Turkey6 |
1,312 |
1,227 |
1,041 |
1,015 |
1,071 |
877 |
691 |
(34)% |
(27)% |
|
Europe |
2,622 |
2,344 |
2,152 |
2,110 |
2,390 |
2,111 |
1,777 |
(17)% |
(10)% |
|
Asia5 |
421 |
446 |
490 |
497 |
623 |
826 |
769 |
57% |
55% |
|
Aviva Investors7 |
5 |
252 |
305 |
319 |
366 |
395 |
404 |
33% |
33% |
|
Total - excluding Eurovita, CxG & South Korea |
6,084 |
6,254 |
6,088 |
5,981 |
5,956 |
8,096 |
7,711 |
27% |
31% |
|
Eurovita, CxG & South Korea |
136 |
156 |
15 |
14 |
- |
- |
- |
- |
- |
|
Total |
6,220 |
6,410 |
6,103 |
5,995 |
5,956 |
8,096 |
7,711 |
26% |
30% |
1 Present value of new business premiums (PVNBP) is the present value of new regular premiums plus 100% of single premiums, calculated using assumptions consistent with those used to determine the value of new business.
2 Currency movements are calculated using unrounded numbers so minor rounding differences may exist.
3 Other UK business includes UK Retail Fund Management and UK long term health business. UK Retail Fund Management business was transferred from UK Life to Aviva Investors on 9 May 2014.
4 United Kingdom includes Friends UK from 10 April 2015.
5 Poland includes Lithuania, Italy excludes Eurovita, Spain excludes CxG. Asia includes FPI from 10 April 2015 and excludes South Korea.
6 The shareholding of Aviva's minority interest in our Turkish joint venture reduced from 49.8% to 41.3% on 13 November 2014 through an initial public offering. Aviva's holding was further reduced to 40.0% on 7 August 2015.
7 The UK Retail Fund Management business was transferred from UK Life to Aviva Investors on 9 May 2014.
8 Includes c.£1 billion PVNBP (net of reinsurance) relating to a longevity insurance transaction completed in 3Q15.
Page 11
8 - Geographical analysis of regular and single premiums
|
|
|
|
|
|
|
|
Regular premiums |
|
|
Single premiums |
|
|
9 months 2015 £m |
Constant currency growth1 |
WACF |
Present value £m |
9 months 2014 £m |
WACF |
Present value £m |
9 months 2015 £m |
9 months 2014 £m |
Constant currency growth1 |
|
United Kingdom2,7 |
1,029 |
39% |
6.1 |
6,236 |
740 |
5.0 |
3,699 |
5,460 |
5,399 |
1% |
|
Ireland |
18 |
3% |
6.1 |
109 |
19 |
5.1 |
97 |
297 |
194 |
71% |
|
United Kingdom & Ireland |
1,047 |
38% |
6.1 |
6,345 |
759 |
5.0 |
3,796 |
5,757 |
5,593 |
3% |
|
France |
63 |
10% |
9.0 |
570 |
63 |
8.1 |
512 |
3,069 |
3,026 |
13% |
|
Poland3 |
29 |
(16)% |
7.9 |
228 |
39 |
8.8 |
344 |
91 |
85 |
19% |
|
Italy - excluding Eurovita |
9 |
(71)% |
7.3 |
66 |
33 |
5.6 |
185 |
1,452 |
1,875 |
(14)% |
|
Spain - excluding CxG |
23 |
(4)% |
6.1 |
140 |
27 |
5.7 |
154 |
315 |
589 |
(40)% |
|
Turkey4 |
72 |
2% |
3.9 |
280 |
80 |
3.8 |
301 |
67 |
47 |
61% |
|
Europe |
196 |
(10)% |
6.6 |
1,284 |
242 |
6.2 |
1,496 |
4,994 |
5,622 |
(1)% |
|
Asia5 - excluding South Korea |
240 |
41% |
6.8 |
1,621 |
166 |
6.5 |
1,087 |
597 |
270 |
118% |
|
Aviva Investors6 |
- |
- |
- |
- |
- |
- |
- |
1,165 |
562 |
107% |
|
Total - excluding Eurovita, CxG & South Korea |
1,483 |
30% |
6.2 |
9,250 |
1,167 |
5.5 |
6,379 |
12,513 |
12,047 |
9% |
|
Eurovita, CxG & South Korea |
- |
- |
- |
- |
33 |
3.9 |
130 |
- |
177 |
- |
|
Total |
1,483 |
26% |
6.2 |
9,250 |
1,200 |
5.4 |
6,509 |
12,513 |
12,224 |
8% |
1 Currency movements are calculated using unrounded numbers so minor rounding differences may exist.
2 United Kingdom includes Friends UK from 10 April 2015.
3 Poland includes Lithuania.
4 The shareholding of Aviva's minority interest in our Turkish joint venture reduced from 49.8% to 41.3% on 13 November 2014 through an initial public offering. Aviva's holding was further reduced to 40.0% on 7 August 2015.
5 Asia includes FPI from 10 April 2015.
6 The UK Retail Fund Management business was transferred from UK Life to Aviva Investors on 9 May 2014.
7 Includes c.£1 billion PVNBP (net of reinsurance) relating to a longevity insurance transaction completed in 3Q15.
9 - Trend analysis of Investment sales - cumulative
|
|
|
|
|
|
|
|
|
|
Growth2 on 3Q14 |
|
Investment sales1 |
1Q14 YTD £m |
2Q14 YTD £m |
3Q14 YTD £m |
4Q14 YTD £m |
1Q15 YTD £m |
2Q15 YTD £m |
3Q15 YTD £m |
Sterling |
Constant currency % |
|
United Kingdom & Ireland3 |
486 |
1,043 |
1,405 |
1,742 |
271 |
710 |
1,041 |
(26)% |
(26)% |
|
Aviva Investors4 |
730 |
1,616 |
2,195 |
3,089 |
1,073 |
2,102 |
3,475 |
58% |
69% |
|
Asia5 |
36 |
75 |
110 |
146 |
41 |
78 |
103 |
(6)% |
(7)% |
|
Total investment sales |
1,252 |
2,734 |
3,710 |
4,977 |
1,385 |
2,890 |
4,619 |
25% |
29% |
1 Investment sales are calculated as new single premiums plus the annualised value of new regular premiums.
2 Currency movements are calculated using unrounded numbers so minor rounding differences may exist.
3 Some of UK & Ireland investment sales are also reported in UK Life PVNBP following the extension of MCEV covered business in 2014. 2014 Investment sales are included at the same amount in UK Life 2014 PVNBP. 3Q15 YTD investment sales of £1,041 million are equivalent to £1,110 million on a PVNBP basis.
4 The UK Retail Fund Management business was transferred from UK Life to Aviva Investors on 9 May 2014. YTD investment sales of £250 million for 2Q14, £549 million for 3Q14, £864 million for 4Q14, £362 million for 1Q15, £755 million for 2Q15 and £1,156 million for 3Q15 are also included in Aviva Investors' PVNBP at the same level following the extension of MCEV covered business.
5 Some of Asia investment sales are also reported in Asia PVNBP following an extension of MCEV covered business in 2015.
10 - Trend analysis of Investment sales - discrete
|
|
|
|
|
|
|
|
|
|
Growth2 on 3Q14 |
|
Investment sales1 |
1Q14 Discrete £m |
2Q14 Discrete £m |
3Q14 Discrete £m |
4Q14 Discrete £m |
1Q15 Discrete £m |
2Q15 Discrete £m |
3Q15 Discrete £m |
Sterling |
Constant currency % |
|
United Kingdom & Ireland3 |
486 |
557 |
362 |
337 |
271 |
439 |
331 |
(9)% |
(9)% |
|
Aviva Investors4 |
730 |
886 |
579 |
894 |
1,073 |
1,029 |
1,373 |
137% |
142% |
|
Asia5 |
36 |
39 |
35 |
36 |
41 |
37 |
25 |
(29)% |
(29)% |
|
Total investment sales |
1,252 |
1,482 |
976 |
1,267 |
1,385 |
1,505 |
1,729 |
77% |
79% |
1 Investment sales are calculated as new single premiums plus the annualised value of new regular premiums.
2 Currency movements are calculated using unrounded numbers so minor rounding differences may exist.
3 Some of UK & Ireland investment sales are also reported in UK Life PVNBP following the extension of MCEV covered business in 2014. 2014 Investment sales are included at the same amount in UK Life 2014 PVNBP. 1Q15 investment sales of £271 million, 2Q15 investment sales of £439 million and 3Q15 investment sales of £331 million are equivalent to £295 million, £479 million and £336 million respectively on a PVNBP basis.
4 The UK Retail Fund Management business was transferred from UK Life to Aviva Investors on 9 May 2014. Discrete investment sales of £250 million for 2Q14, £299 million for 3Q14, £315 million for 4Q14, £362 million for 1Q15, £393 million for 2Q15 and £401 million for 3Q15 are also included in Aviva Investors' PVNBP at the same level following the extension of MCEV covered business.
5 Some of Asia investment sales are also reported in Asia PVNBP following an extension of MCEV covered business in 2015.
11 - Geographical analysis of regular and single premiums - investment sales
|
|
|
|
Regular |
|
|
Single |
PVNBP |
|
Investment sales1 |
9 months 2015 £m |
9 months 2014 £m |
Constant currency growth2 |
9 months 2015 £m |
9 months 2014 £m |
Constant currency growth2 |
Constant currency growth2 |
|
United Kingdom & Ireland3 |
18 |
19 |
(4)% |
1,023 |
1,386 |
(26)% |
(26)% |
|
Aviva Investors4 |
4 |
4 |
4% |
3,471 |
2,191 |
69% |
69% |
|
Asia5 |
- |
- |
- |
103 |
110 |
(7)% |
(7)% |
|
Total investment sales |
22 |
23 |
(2)% |
4,597 |
3,687 |
29% |
29% |
1 Investment sales are calculated as new single premiums plus the annualised value of new regular premiums.
2 Currency movements are calculated using unrounded numbers so minor rounding differences may exist.
3 Some of UK & Ireland investment sales are also reported in UK Life PVNBP following the extension of MCEV covered business in 2014. 2014 Investment sales are included at the same amount in UK Life 2014 PVNBP. 3Q15 YTD investment sales of £1,041 million are equivalent to £1,110 million on a PVNBP basis.
4 The UK Retail Fund Management business was transferred from UK Life to Aviva Investors on 9 May 2014. YTD investment sales of £250 million for 2Q14, £549 million for 3Q14, £864 million for 4Q14, £362 million for 1Q15, £755 million for 2Q15 and £1,156 million for 3Q15 are also included in Aviva Investors' PVNBP at the same level following the extension of MCEV covered business.
5 Some of Asia investment sales are also reported in Asia PVNBP following an extension of MCEV covered business in 2015.
Page 12
12 - Trend analysis of general insurance and health net written premiums - cumulative
|
|
|
|
|
|
|
|
|
|
Growth1 on 3Q14 |
|
|
1Q14 YTD £m |
2Q14 YTD £m |
3Q14 YTD £m |
4Q14 YTD £m |
1Q15 YTD £m |
2Q15 YTD £m |
3Q15 YTD £m |
Sterling |
Constant currency % |
|
General insurance |
|
|
|
|
|
|
|
|
|
|
United Kingdom2 |
845 |
1,836 |
2,742 |
3,663 |
855 |
1,851 |
2,750 |
- |
- |
|
Ireland |
65 |
136 |
205 |
272 |
63 |
134 |
210 |
3% |
14% |
|
United Kingdom & Ireland |
910 |
1,972 |
2,947 |
3,935 |
918 |
1,985 |
2,960 |
- |
1% |
|
Europe |
440 |
747 |
999 |
1,313 |
399 |
674 |
910 |
(9)% |
1% |
|
Canada |
426 |
1,026 |
1,584 |
2,104 |
409 |
1,013 |
1,519 |
(4)% |
2% |
|
Asia & Other |
7 |
12 |
15 |
20 |
3 |
6 |
8 |
(47)% |
(47)% |
|
|
1,783 |
3,757 |
5,545 |
7,372 |
1,729 |
3,678 |
5,397 |
(3)% |
1% |
|
Health insurance |
|
|
|
|
|
|
|
|
|
|
United Kingdom3 |
144 |
302 |
394 |
518 |
158 |
315 |
423 |
7% |
7% |
|
Ireland |
33 |
47 |
65 |
93 |
28 |
42 |
58 |
(10)% |
- |
|
United Kingdom & Ireland |
177 |
349 |
459 |
611 |
186 |
357 |
481 |
5% |
6% |
|
Europe |
94 |
138 |
182 |
243 |
89 |
128 |
157 |
(14)% |
(4)% |
|
Asia4 |
29 |
45 |
61 |
74 |
33 |
55 |
75 |
23% |
24% |
|
|
300 |
532 |
702 |
928 |
308 |
540 |
713 |
2% |
5% |
|
Total |
2,083 |
4,289 |
6,247 |
8,300 |
2,037 |
4,218 |
6,110 |
(2)% |
2% |
1 Currency movements are calculated using unrounded numbers so minor rounding differences may exist.
2 Excludes the one-off impact from an outward quota share reinsurance agreement completed in 2015 in Aviva Insurance Limited (AIL).
3 These premiums are also reported in UK Life PVNBP following the extension of MCEV covered business in 2014. 1Q14 NWP of £144 million, 2Q14 YTD NWP of £302 million, 3Q14 YTD NWP of £394 million, 4Q14 YTD NWP of £518 million, 1Q15 NWP of £158 million, 2Q15 YTD NWP of £315 million and 3Q15 YTD NWP of £423 million are equivalent to £158 million, £368 million, £497 million, £542 million, £182 million, £373 million and £452 million on a PVNBP basis respectively.
4 Singapore long term health business is also reported in Asia PVNBP following the extension of MCEV covered business in 2014. For Singapore long term health business, 1Q14 NWP of £5 million, 2Q14 YTD NWP of £9 million, 3Q14 YTD NWP of £15 million, 4Q14 YTD NWP of £22 million, 1Q15 NWP of £10 million, 2Q15 YTD NWP of £23 million and 3Q15 YTD NWP of £36 million are equivalent to £37 million, £87 million, £130 million, £183 million, £48 million, £120 million and £184 million on a PVNBP basis respectively.
13 - Trend analysis of general insurance and health net written premiums - discrete
|
|
|
|
|
|
|
|
|
|
Growth1 on 3Q14 |
|
|
1Q14 Discrete £m |
2Q14 Discrete £m |
3Q14 Discrete £m |
4Q14 Discrete £m |
1Q15 Discrete £m |
2Q15 Discrete £m |
3Q15 Discrete £m |
Sterling |
Constant currency % |
|
General insurance |
|
|
|
|
|
|
|
|
|
|
United Kingdom2 |
845 |
991 |
906 |
921 |
855 |
996 |
899 |
(1)% |
(1)% |
|
Ireland |
65 |
71 |
69 |
67 |
63 |
71 |
76 |
11% |
22% |
|
United Kingdom & Ireland |
910 |
1,062 |
975 |
988 |
918 |
1,067 |
975 |
- |
1% |
|
Europe |
440 |
307 |
252 |
314 |
399 |
275 |
236 |
(7)% |
1% |
|
Canada |
426 |
600 |
558 |
520 |
409 |
604 |
506 |
(9)% |
(3)% |
|
Asia & Other |
7 |
5 |
3 |
5 |
3 |
3 |
2 |
(53)% |
(53)% |
|
|
1,783 |
1,974 |
1,788 |
1,827 |
1,729 |
1,949 |
1,719 |
(4)% |
- |
|
Health insurance |
|
|
|
|
|
|
|
|
|
|
United Kingdom3 |
144 |
158 |
92 |
124 |
158 |
157 |
108 |
18% |
18% |
|
Ireland |
33 |
14 |
18 |
28 |
28 |
14 |
16 |
(11)% |
(3)% |
|
United Kingdom & Ireland |
177 |
172 |
110 |
152 |
186 |
171 |
124 |
13% |
15% |
|
Europe |
94 |
44 |
44 |
61 |
89 |
39 |
29 |
(33)% |
(27)% |
|
Asia4 |
29 |
16 |
16 |
13 |
33 |
22 |
20 |
28% |
29% |
|
|
300 |
232 |
170 |
226 |
308 |
232 |
173 |
3% |
6% |
|
Total |
2,083 |
2,206 |
1,958 |
2,053 |
2,037 |
2,181 |
1,892 |
(3)% |
- |
1 Currency movements are calculated using unrounded numbers so minor rounding differences may exist.
2 Excludes the one-off impact from an outward quota share reinsurance agreement completed in 2015 in Aviva Insurance Limited (AIL).
3 These premiums are also reported in UK Life PVNBP following the extension of MCEV covered business in 2014. 1Q14 NWP of £144 million, 2Q14 NWP of £158 million, 3Q14 NWP of £92 million, 4Q14 NWP of £124 million, 1Q15 NWP of £158 million, 2Q15 NWP of £157 million and 3Q15 NWP of £108 million are equivalent to £158 million, £210 million, £129 million, £45 million, £182 million, £191 million and £79 million on a PVNBP basis respectively.
4 Singapore long term health business is also reported in Asia PVNBP following the extension of MCEV covered business in 2014. For Singapore long term health business, 1Q14 NWP of £5 million, 2Q14 NWP of £4 million, 3Q14 NWP of £6 million, 4Q14 NWP of £7 million, 1Q15 NWP of £10 million, 2Q15 NWP of £13 million and 3Q15 NWP of £13 million are equivalent to £37 million, £50 million, £43 million, £53 million, £48 million, £72 million and £64 million on a PVNBP basis respectively.
This information is provided by RNS
Latest directors dealings
- 3 minutes ago Bluefield Solar Income Fund Limited
- 1 hour ago Halma
- 1 hour ago Barratt Developments
- 3 hours ago Dar Global
- 3 hours ago Audioboom Group